NM_005548.3:c.690A>T
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_005548.3(KARS1):c.690A>T(p.Arg230Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000372 in 1,614,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_005548.3 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 89Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
- leukoencephalopathy, progressive, infantile-onset, with or without deafnessInheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Charcot-Marie-Tooth disease recessive intermediate BInheritance: AR, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nonsyndromic genetic hearing lossInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005548.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KARS1 | NM_005548.3 | MANE Select | c.690A>T | p.Arg230Ser | missense | Exon 6 of 14 | NP_005539.1 | ||
| KARS1 | NM_001130089.2 | c.774A>T | p.Arg258Ser | missense | Exon 7 of 15 | NP_001123561.1 | |||
| KARS1 | NM_001378148.1 | c.222A>T | p.Arg74Ser | missense | Exon 6 of 14 | NP_001365077.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KARS1 | ENST00000302445.8 | TSL:1 MANE Select | c.690A>T | p.Arg230Ser | missense | Exon 6 of 14 | ENSP00000303043.3 | ||
| KARS1 | ENST00000319410.9 | TSL:1 | c.774A>T | p.Arg258Ser | missense | Exon 7 of 15 | ENSP00000325448.5 | ||
| KARS1 | ENST00000566560.5 | TSL:1 | n.804A>T | non_coding_transcript_exon | Exon 6 of 7 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152226Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461878Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74360 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:2
PP3, PM2, PM3, PS4_moderate
Observed in unrelated patients with KARS1-related aminoacyl-tRNA synthetase deficiency in published literature (Schon et al., 2021; Macken et al., 2022); however it is unclear whether the variants are on the same allele (in cis) or on opposite alleles (in trans); Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34172899, 36344503, 34732400)
not specified Pathogenic:1
The c.774A>T (p.R258S) alteration is located in exon 7 (coding exon 6) of the KARS gene. This alteration results from an A to T substitution at nucleotide position 774, causing the arginine (R) at amino acid position 258 to be replaced by a serine (S). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant has been identified in the homozygous state and/or in conjunction with other KARS variant(s) in individual(s) with features consistent with Cytoplasmic and mitochondrial lysyl-tRNA synthetase deficiency; in at least one instance, the variants were identified in trans (Lin, 2021; Macken, 2022). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic.
Leukoencephalopathy, progressive, infantile-onset, with or without deafness Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at